BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29987005)

  • 1. N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylation.
    Bowie LE; Maiuri T; Alpaugh M; Gabriel M; Arbez N; Galleguillos D; Hung CLK; Patel S; Xia J; Hertz NT; Ross CA; Litchfield DW; Sipione S; Truant R
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7081-E7090. PubMed ID: 29987005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Repair Signaling of Huntingtin: The Next Link Between Late-Onset Neurodegenerative Disease and Oxidative DNA Damage.
    Maiuri T; Bowie LE; Truant R
    DNA Cell Biol; 2019 Jan; 38(1):1-6. PubMed ID: 30481056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization.
    DiGiovanni LF; Mocle AJ; Xia J; Truant R
    Hum Mol Genet; 2016 Sep; 25(18):3937-3945. PubMed ID: 27466181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
    Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
    Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinase inhibitors modulate huntingtin cell localization and toxicity.
    Atwal RS; Desmond CR; Caron N; Maiuri T; Xia J; Sipione S; Truant R
    Nat Chem Biol; 2011 May; 7(7):453-60. PubMed ID: 21623356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions.
    Caron NS; Hung CL; Atwal RS; Truant R
    Hum Mol Genet; 2014 May; 23(9):2324-38. PubMed ID: 24334607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
    Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM
    J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease.
    Cong W; Bai R; Li YF; Wang L; Chen C
    ACS Appl Mater Interfaces; 2019 Sep; 11(38):34725-34735. PubMed ID: 31479233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.
    Chang R; Liu X; Li S; Li XJ
    Drug Des Devel Ther; 2015; 9():2179-88. PubMed ID: 25931812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
    Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
    Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.
    André EA; Braatz EM; Liu JP; Zeitlin SO
    J Huntingtons Dis; 2017; 6(1):47-62. PubMed ID: 28211815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.
    Chiu FL; Lin JT; Chuang CY; Chien T; Chen CM; Chen KH; Hsiao HY; Lin YS; Chern Y; Kuo HC
    Hum Mol Genet; 2015 Nov; 24(21):6066-79. PubMed ID: 26264576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease.
    Hernández IH; Torres-Peraza J; Santos-Galindo M; Ramos-Morón E; Fernández-Fernández MR; Pérez-Álvarez MJ; Miranda-Vizuete A; Lucas JJ
    Acta Neuropathol; 2017 Dec; 134(6):839-850. PubMed ID: 28861715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.
    Acevedo-Torres K; Berríos L; Rosario N; Dufault V; Skatchkov S; Eaton MJ; Torres-Ramos CA; Ayala-Torres S
    DNA Repair (Amst); 2009 Jan; 8(1):126-36. PubMed ID: 18935984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease.
    Moruno-Manchon JF; Uzor NE; Blasco-Conesa MP; Mannuru S; Putluri N; Furr-Stimming EE; Tsvetkov AS
    Hum Mol Genet; 2017 Apr; 26(7):1305-1317. PubMed ID: 28175299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.